Evofem Biosciences, Inc.

EVFM · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2-$2$1-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$4-$2$5-$2
Other Non-Cash$5$0-$6$3
Operating Cash Flow$0-$3$1-$2
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0$0-$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$0-$0-$0-$0
Financing Activities
Debt Repay.$0$3-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0-$0-$0$0
Other Fin. Act.-$0$0$0$6
Financing Cash Flow-$0$3-$0$2
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$0$0$0
Supplemental Information
Beg. Cash$1$1$1$1
End Cash$1$1$1$1
Free Cash Flow$0-$3$1-$2
Evofem Biosciences, Inc. (EVFM) Financial Statements & Key Stats | AlphaPilot